M MLTX
MoonLake Immunotherapeutics - Class A
$17.55
-4.57% ($0.84)
Volume
585,044
52W High
$62.75
52W Low
$5.95
Market Cap
$1.24B
Next Earnings Report
Last Reported
May 11, 2026 Missed
Actual: -$0.98
vs. Consensus: -$0.92
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 11, 2026
1-Day:
-3.45%
Q1 2026
Mar 31, 2026
1-Day:
-11.37%
Q4 2025
Feb 26, 2026
1-Day:
-0.96%
5-Day:
+0.06%
Q4 2025
Feb 25, 2026
1-Day:
-2.96%
5-Day:
-2.96%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'24 | $101,850 | -- | 50.0% | -10,000.0% | -$45.6M |
| Q1'24 | $19,738 | -- | -115.6% | -10,000.0% | -$13.7M |
| Q4'23 | $19,738 | -- | 83.3% | -10,000.0% | -$7.4M |
Company Information
Symbol
MLTX
Company
MoonLake Immunotherapeutics - Class A
Market Cap
$1.24B